advanced MS

Trial Will Test Mavenclad for Advanced Progressive MS

After some delays due to the COVID-19 pandemic, the Phase 2/3 clinical trial evaluating whether Mavenclad (cladribine) can slow hand and arm function worsening in adults with progressive multiple sclerosis (MS) and very limited walking abilities, has recruited its first patient. The study,Ā ChariotMS (NCT04695080), aims to…

Study Finds PoNS Neurostimulator Plus Physical Therapy of Benefit to Advanced MS Patients

Helius Medical Technologies announced results of a pilot study, demonstrating the benefits ofĀ PoNS Therapy ā€” aĀ combination of the investigational Portable Neuromodulation Stimulator (PoNS) device with physical therapy ā€” in patients with advanced multiple sclerosis (MS). Specifically, the treatmentĀ was seen to improve both patients’ quality of life, andĀ physical and…